Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01270243 · ClinicalTrials.gov registry record
Bacterial Microbiota In The Tonsils Of Children
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 24
- Enrollment target
NCT01270243: Completed study, sponsored by University of Chicago.
NCT01270243 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01270243 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
We, the investigators, propose to look at the bacteria on and in tonsils using gene microarrays. We expect to find previously reported bacteria but also the possibility of previously undetected organisms. We think that the bacterial pathogens present on the tonsillar surface are different from the tonsil core. And we also think that the bacteria of the tonsil surface will differ between patients undergoing adenotonsillectomy and normal controls with no adenotonsillar problems.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-12-01 |
| Est. Completion | 2017-02-18 |
What the finished NCT01270243 record still lists
NCT01270243 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01270243 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01270243 about?
NCT01270243 is a clinical study titled "Bacterial Microbiota In The Tonsils Of Children". We, the investigators, propose to look at the bacteria on and in tonsils using gene microarrays. We expect to find previously reported bacteria but also the possibility of previously undetected organisms. We think that the bacterial pathogens present on the tonsillar surface are different from the t...
What is the current status of trial NCT01270243?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2010-12-01. Estimated completion is 2017-02-18.
Who is sponsoring clinical trial NCT01270243?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI